
A retrospective study of 192 patients (2014–2021) found that surgery followed by chemoradiotherapy (CRT) led to the best survival rates. Induction chemotherapy (ICT) improved outcomes for responsive patients. Pathological type and surgery were key prognostic factors. These findings emphasize the importance of combined and personalized treatment approaches to enhance patient survival and quality of life.
Like
Save
Share